AstraZeneca's cancer drug Acalabrutinib likely to help in treating COVID-19 patients with breathing... - Firstpost 09-Jun-2020

AstraZeneca's cancer drug Acalabrutinib likely to help in treating COVID-19 patients with breathing... - Firstpost

A study showed that acalabrutinib reduced the levels of interleukin-6 (IL-6) in the blood, which is otherwise responsible for creating inflammation in the body of COVID-19 patients.